What is the main business of Leenlife Pharma?

The main business activity of Leenlife Pharma focuses on non-specialised wholesale trade.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 25, 2013.

Where is the headquarters located?

The headquarters is located at: ul. Gen. Juliana Filipowicza 2, 30-611 Kraków.

Who is on the management board?

The management board consists of: Zbigniew Powierża (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from July 1, 2023 to June 30, 2024.

What was the revenue?

The company reported a revenue of $47,609 in 2024, which is an increase of 73.1% compared to 2023.

Is the company profitable?

Yes, in 2024 the company achieved a net profit of $10,918.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $4,966 in 2024, representing 48% of all operating expenses.

Leenlife PharmaS.A.

Non-specialised wholesale trade

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2013-06-25

Share capital

100 000,00 PLN

Activity description

Leenlife Pharma is a company that offers a patented nutraceutical product called Omega3+6concept, which is designed to positively modulate physiological functions and improve health. Their products are aimed at enhancing heart health, mental well-being, and immunity. The company emphasizes the health benefits of their offerings, including improved skin appearance and overall well-being.

Registered address

ul. Gen. Juliana Filipowicza 2/7, 30-611 Kraków, Poland

Website

leenlife.com

Phone

Electronic delivery address

AE:PL-58575-49022-VEUBG-12

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 47.61kMedianUSD 614.05kAverageUSD 7.52m

Net profit

This companyUSD 10.92kMedianUSD 12.08kAverageUSD 230.15k

Operating costs

This companyUSD 10.31kMedianUSD 566.36kAverageUSD 6.98m

Assets

This companyUSD 4.38kMedianUSD 363.48kAverageUSD 3.39m

Industry

Bank accounts

Registered as a VAT taxpayer on 2013-07-02. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication date	Event
Jun 30, 2025	Shareholders' meeting convened
Nov 24, 2016	Commercial Companies Code notice
Nov 10, 2016	Shareholders' meeting convened
Oct 19, 2016	Commercial Companies Code notice
Sep 19, 2016	Shareholders' meeting convened

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Zbigniew Powierża — President of the Management Board

Manner of representation

1. In the case of a one-person management board, the President of the Management Board is authorised to make declarations of will and incur liabilities on behalf of the company. 2. In the case where the management board is multi-member, the President of the Management Board independently, or two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy, is authorised to make declarations of will and incur liabilities on behalf of the company.

Supervisory board

Karolina Stącel — Supervisory Board Member

Tadeusz Stanisław Zając — Supervisory Board Member

Beneficial owners

Person	Rights
Halina Pęczkowska (57)	Shareholder of a joint-stock company, 58.0%
Piotr Konrad Zając (52)	Shareholder of a joint-stock company, 42.0%

Competitors

Name	Revenue	Website
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Food SectorP.S.A.	$180,336.24	foodsector.pl
BL Medicasp. z o.o.	$148,305.98	blmedica.pl
NutrisleP.S.A.	$135,614.44	nutrisle.com
Pharmbiopolsp. z o.o.	$99,211.10	pharmbiopol.com
Lifepointone.Vetsp. z o.o.	$37,036.57	lifepointone.vet
Nanotechsp. z o.o.	$29,695.92	hyamatrix.pl
Tussasp. z o.o.	$23,880.55	tussa.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Souvresp. z o.o. + limited partnership	$15,067.81	souvre.com

Change history

Date	Event
2015-06-17	Address change (Burmistrza Marka 4, 32-400, Myślenice → Ul. Gen. Juliana Filipowicza 2/7, 30-611, Kraków)
2015-06-17	PKD change (Removed: 01.61.Z, 01.62.Z, 01.63.Z, 01.64.Z, 10.11.Z, 10.12.Z, 10.13.Z, 10.42.Z, 10.51.Z, 10.52.Z, 10.61.Z, 10.62.Z, 10.71.Z, 10.72.Z, 10.73.Z, 10.86.Z, 10.89.Z, 10.91.Z, 10.92.Z, 11.07.Z, 20.13.Z, 20.14.Z, 20.41.Z, 20.42.Z, 20.59.Z, 21.20.Z, 32.99.Z, 33.20.Z, 46.11.Z, 46.17.Z, 46.18.Z, 46.19.Z, 46.31.Z, 46.32.Z, 46.33.Z, 46.34.A, 46.34.B, 46.36.Z, 46.38.Z, 46.39.Z, 46.45.Z, 46.46.Z, 46.49.Z, 46.75.Z, 46.76.Z, 46.77.Z, 47.11.Z, 47.19.Z, 47.21.Z, 47.22.Z, 47.23.Z, 47.24.Z, 47.25.Z, 47.26.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.76.Z, 47.78.Z, 47.99.Z, 49.41.Z, 52.10.B, 52.21.Z, 52.24.C, 52.29.C, 58.11.Z, 58.14.Z, 58.19.Z, 63.99.Z, 64.99.Z, 68.10.Z, 68.20.Z, 70.22.Z, 71.12.Z, 71.20.B, 72.19.Z, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 74.10.Z, 74.90.Z, 77.12.Z, 77.31.Z, 77.39.Z, 82.11.Z, 82.19.Z, 82.30.Z, 82.92.Z, 82.99.Z, 85.59.B, 85.60.Z, 94.11.Z, 94.12.Z, 94.99.Z)
2014-03-04	Address change (H. Cegielskiego 2, 32-400, Myślenice → Burmistrza Marka 4, 32-400, Myślenice)
2013-06-25	Entered in the register

FAQ

Last updated: 2026-03-24